Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient
Clinical trial NCT03294798 · COMPLETED
Trial details
- NCT number
- NCT03294798
- Sponsor
- Tianjin SinoBiotech Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2019-03-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.